FCM

Farallon Capital Management Portfolio holdings

AUM $21.3B
This Quarter Return
+18.86%
1 Year Return
+23.12%
3 Year Return
+87.19%
5 Year Return
+183.94%
10 Year Return
+836.54%
AUM
$16.1B
AUM Growth
+$16.1B
Cap. Flow
+$342M
Cap. Flow %
2.12%
Top 10 Hldgs %
31.86%
Holding
165
New
37
Increased
28
Reduced
33
Closed
28

Top Buys

1
ARMK icon
Aramark
ARMK
$424M
2
XLNX
Xilinx Inc
XLNX
$362M
3
ALXN
Alexion Pharmaceuticals Inc
ALXN
$351M
4
RTX icon
RTX Corp
RTX
$325M
5
AVGO icon
Broadcom
AVGO
$273M

Top Sells

1
IMMU
Immunomedics Inc
IMMU
$498M
2
ABBV icon
AbbVie
ABBV
$332M
3
INFO
IHS Markit Ltd. Common Shares
INFO
$299M
4
PANW icon
Palo Alto Networks
PANW
$217M
5
BMY icon
Bristol-Myers Squibb
BMY
$217M

Sector Composition

1 Healthcare 39.5%
2 Communication Services 13.65%
3 Financials 10.37%
4 Technology 10.17%
5 Industrials 8.76%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
DMTK
76
DELISTED
DermTech, Inc. Common Stock
DMTK
$27.9M 0.17%
861,090
-358,909
-29% -$11.6M
BIIB icon
77
Biogen
BIIB
$20.8B
$25.2M 0.15%
+103,000
New +$25.2M
CNST
78
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$21.6M 0.13%
+750,000
New +$21.6M
BEKE icon
79
KE Holdings
BEKE
$21.8B
$21.1M 0.13%
343,000
+8,000
+2% +$492K
GRFS icon
80
Grifois
GRFS
$6.53B
$20.6M 0.12%
1,115,000
-2,013,750
-64% -$37.1M
ZEAL
81
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
$18.3M 0.11%
510,000
+5,000
+1% +$180K
ATTO
82
DELISTED
Atento S.A.
ATTO
$18.2M 0.11%
2,230,357
– –
PLRX icon
83
Pliant Therapeutics
PLRX
$105M
$17.4M 0.1%
764,262
– –
DCPH
84
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$17.1M 0.1%
300,000
-30,000
-9% -$1.71M
INBX
85
DELISTED
Inhibrx, Inc. Common Stock
INBX
$16.8M 0.1%
510,000
+115,000
+29% +$3.79M
RC
86
Ready Capital
RC
$695M
$16.8M 0.1%
1,350,226
– –
ADVM icon
87
Adverum Biotechnologies
ADVM
$68.2M
$16.3M 0.1%
1,500,000
– –
BMY icon
88
Bristol-Myers Squibb
BMY
$96.7B
$15.5M 0.09%
250,000
-3,500,000
-93% -$217M
BMY.RT
89
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$14.8M 0.09%
21,400,000
-22,673,000
-51% -$15.6M
PRAX icon
90
Praxis Precision Medicines
PRAX
$980M
$13.8M 0.08%
+250,000
New +$13.8M
XPO icon
91
XPO
XPO
$14.8B
$13.1M 0.08%
+110,000
New +$13.1M
NTLA icon
92
Intellia Therapeutics
NTLA
$1.26B
$12.2M 0.07%
+225,000
New +$12.2M
TINV.U
93
DELISTED
Tiga Acquisition Corp. Units, each consisting of one Class A ordinary share and one half of one warrant
TINV.U
$11.4M 0.07%
+1,080,000
New +$11.4M
TECX
94
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
$11.1M 0.07%
795,000
-255,000
-24% -$3.55M
RCKT icon
95
Rocket Pharmaceuticals
RCKT
$358M
$11M 0.07%
+200,000
New +$11M
QURE icon
96
uniQure
QURE
$954M
$10.8M 0.07%
300,000
-150,000
-33% -$5.42M
CAS.U
97
DELISTED
Cascade Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half o
CAS.U
$10.3M 0.06%
+990,000
New +$10.3M
KNTE
98
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$9.95M 0.06%
+250,000
New +$9.95M
ALBO
99
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
$9.38M 0.06%
250,000
+50,000
+25% +$1.88M
SURF
100
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$9.24M 0.06%
+1,000,000
New +$9.24M
2 3
4
5 6